-
Product Insights
NewInsulin Pumps Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
An insulin pump is an insulin delivery device that administers programmed doses of insulin for diabetes management. An Insulin Pump consists of a battery run pump, an insulin reservoir and an infusion set with a tubing system for subcutaneous intervention. GlobalData's Medical Devices sector report, “Insulin Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Insulin Pumps pipeline products with comparative analysis of the products at...
-
Innovation Ranking
Innovation Ranking – 9 Meters Biopharma Inc
9 Meters Biopharma Inc (9 Meters Biopharma), formerly Innovate Biopharmaceuticals Inc, is a clinical-stage biopharmaceutical company developing novel medicines for autoimmune and inflammatory diseases. The company’s pipeline products include Larazotide, an orally administered, gut-restricted tight-junction regulator for celiac disease, NM-003, a long-acting GLP-2 analog, under orphan indication selection, NM-136 and NM-004. 9 Meters Biopharma is headquartered in Raleigh, North Carolina, the US.
-
Product Insights
NewShort Bowel Syndrome – Drugs In Development, 2024
Empower your strategies with our Short Bowel Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the small and/or large intestine. Symptoms include bloating, cramping, fatigue, heartburn, vomiting, weakness, and diarrhea. Complications of short bowel syndrome include malnutrition, peptic ulcers, kidney stones, and small intestinal bacterial overgrowth. Treatment includes vitamin and mineral supplements, antibiotics,...
-
Product Insights
NewPrader-Willi Syndrome (PWS) – Drugs In Development, 2024
Empower your strategies with our Prader-Willi Syndrome (PWS) – Drugs In Development, 2024 report and make more profitable business decisions. Prader-Willi syndrome (PWS) is a rare congenital genetic disorder that results in a number of physical, mental, and behavioral problems. PWS is due to the lack of several genes on one of an individual’s two chromosome 15s. In the majority of cases, there is a deletion. In the remaining cases, the entire chromosome from the father is missing and there are...
-
Product Insights
NewHigh-Grade Glioma – Drugs In Development, 2024
Empower your strategies with our High-Grade Glioma – Drugs In Development, 2024 report and make more profitable business decisions. High-grade gliomas (HGGs) are tumors of the central nervous system that arise from mutated cells of the brain and spinal cord. Symptoms include developmental delay, headaches, backaches, nausea and vomiting, dizziness, gait disturbances, impaired vision, lack of concentration, drowsiness, sleep disturbances, dysregulated appetite, paralysis, and seizures. Treatment includes chemotherapy and radiation therapy. The High-Grade Glioma drugs in development market research report provide...
-
Product Insights
NewRadiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – Drugs In Development, 2024
Empower your strategies with our Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – Drugs In Development, 2024 report and make more profitable business decisions. Radiation toxicity (also known as radiation sickness) is an acute illness caused by irradiation of the entire body by a high dose of ionizing radiation over a very short period of time (usually a matter of minutes). The root cause of this syndrome is depletion of immature parenchymal stem cells in specific tissues. Symptoms include bleeding from...
-
Product Insights
NewPruritus – Drugs In Development, 2024
Empower your strategies with our Pruritus – Drugs In Development, 2024 report and make more profitable business decisions. Pruritus, or itch, is defined as an unpleasant sensation that provokes the desire to scratch. Pruritus is caused by cancer, cancer treatments, infection, dry skin, and reactions to drugs. Symptoms include redness, bumps, spots or blisters, dry, cracked skin, and leathery or scaly texture to the skin. Risk factors include heat, allergies, asthma, hay fever, hives, and eczema. Treatment includes corticosteroids, antihistamines, and...
-
Product Insights
NewColitis – Drugs In Development, 2024
Empower your strategies with our Colitis – Drugs In Development, 2024 report and make more profitable business decisions. Colitis is swelling (inflammation) of the large intestine (colon). Colitis can have many different causes, including infections with a virus or parasite or bacterial food poisoning; inflammatory disorders, namelsy ulcerative colitis and Crohn's disease; lack of blood flow (ischemic colitis); or past radiation exposure to the large bowel. Symptoms can include abdominal pain, bloating, bloody stools, chills, dehydration, diarrhea, and fever. Treatment includes...
-
Product Insights
NewInterstitial Lung Fibrosis – Drugs In Development, 2024
Empower your strategies with our Interstitial Lung Fibrosis – Drugs In Development, 2024 report and make more profitable business decisions. Interstitial Lung Fibrosis or interstitial lung disease (ILD) is a group of diseases that cause scarring of the lungs (fibrosis) or lung parenchyma. If untreated it can lead to respiratory failure and death. Symptoms start with inflammation and can result in bronchiolitis, vasculitis, and alveolitis. Exposure to hazardous chemicals or materials like asbestos, hypersensitivity, drug-induced, underlying autoimmune conditions, family history, smoking,...
-
Product Insights
NewCryopyrin-Associated Periodic Syndromes – Drugs In Development, 2024
Empower your strategies with our Cryopyrin-Associated Periodic Syndromes – Drugs In Development, 2024 report and make more profitable business decisions. cryopyrin-associated periodic syndromes are a group of autoimmune diseases caused by a defect in the cryopyrin protein. Genetic mutations on the NLRP3 gene result in overproduction of interleukin 1 beta due to excessive inflammasome activation. This is generally seen in children and is a rare form. It includes Neonatal Onset Multisystem Inflammatory Disease (NOMID), Muckle-Wells Syndrome (MWS) and Familial Cold Autoinflammatory...